Tarsus Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 11/12/2025 | 3.78 M | $224.62 M | -0.33% | 8.92% |
| RTW INVESTMENTS, LP | 11/14/2025 | 3.18 M | $188.84 M | 2.11% | 7.50% |
| DEEP TRACK CAPITAL, LP | 11/14/2025 | 3.00 M | $178.29 M | 71.43% | 7.08% |
| PARADIGM BIOCAPITAL ADVISORS LP | 11/14/2025 | 2.67 M | $158.42 M | -10.43% | 6.29% |
| JENNISON ASSOCIATES LLC | 10/30/2025 | 2.60 M | $154.79 M | 5.53% | 6.15% |
| TANG CAPITAL MANAGEMENT LLC | 11/14/2025 | 2.45 M | $145.89 M | 0.00% | 5.80% |
| VANGUARD GROUP INC | 11/07/2025 | 2.27 M | $135.03 M | -1.10% | 5.36% |
| MORGAN STANLEY | 11/14/2025 | 1.91 M | $113.65 M | -6.97% | 4.51% |
| JANUS HENDERSON GROUP PLC | 11/14/2025 | 1.44 M | $85.55 M | -20.36% | 3.40% |
| ASSENAGON ASSET MANAGEMENT S.A. | 10/07/2025 | 1.25 M | $74.17 M | 25.10% | 2.95% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 11/14/2025 | 1.17 M | $69.39 M | -16.46% | 2.76% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 11/14/2025 | 1.03 M | $61.27 M | 17.63% | 2.43% |
| LORD, ABBETT & CO. LLC | 11/13/2025 | 985.63 K | $58.58 M | -0.98% | 2.33% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 944.50 K | $56.14 M | 1.08% | 2.23% |
| INVESCO LTD. | 11/13/2025 | 937.01 K | $55.69 M | 0.92% | 2.21% |
| STATE STREET CORP | 11/14/2025 | 936.16 K | $55.64 M | -4.56% | 2.21% |
| MACQUARIE GROUP LTD | 11/13/2025 | 833.44 K | $49.53 M | -12.16% | 1.97% |
| TORONTO DOMINION BANK | 11/14/2025 | 617.58 K | $36.70 M | -38.36% | 1.46% |
| D. E. SHAW & CO., INC. | 11/14/2025 | 598.31 K | $35.56 M | -17.27% | 1.41% |
| CLEARBRIDGE INVESTMENTS, LLC | 11/13/2025 | 566.98 K | $33.70 M | 27.55% | 1.34% |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | 11/12/2025 | 558.33 K | $33.18 M | 3.53% | 1.32% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 536.02 K | $31.86 M | 14.96% | 1.27% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2025 | 522.28 K | $31.04 M | 13.68% | 1.23% |
| ENSIGN PEAK ADVISORS, INC | 11/13/2025 | 482.36 K | $28.67 M | -1.02% | 1.14% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2025 | 452.86 K | $26.91 M | 17.96% | 1.07% |
| LOOMIS SAYLES & CO L P | 11/13/2025 | 389.90 K | $23.17 M | 100.00% | 0.92% |
| NORTHERN TRUST CORP | 11/14/2025 | 358.10 K | $21.28 M | 0.26% | 0.85% |
| BIOIMPACT CAPITAL LLC | 11/14/2025 | 341.50 K | $20.30 M | 0.00% | 0.81% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 341.01 K | $20.27 M | -14.32% | 0.81% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 332.91 K | $19.78 M | 1.10% | 0.79% |
| NUVEEN, LLC | 11/12/2025 | 330.68 K | $19.65 M | -1.86% | 0.78% |
| CORMORANT ASSET MANAGEMENT, LP | 11/14/2025 | 300.00 K | $17.83 M | 0.00% | 0.71% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 11/14/2025 | 288.34 K | $17.14 M | -22.85% | 0.68% |
| TIMESSQUARE CAPITAL MANAGEMENT, LLC | 11/07/2025 | 267.51 K | $15.90 M | 100.00% | 0.63% |
| JUMP FINANCIAL, LLC | 11/13/2025 | 266.01 K | $15.81 M | 12.18% | 0.63% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 11/14/2025 | 250.00 K | $14.86 M | 25.00% | 0.59% |
| CAPRICORN FUND MANAGERS LTD | 10/17/2025 | 240.02 K | $14.26 M | 100.00% | 0.57% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 204.30 K | $12.14 M | 34.14% | 0.48% |
| ORBIMED ADVISORS LLC | 11/14/2025 | 197.90 K | $11.76 M | 0.00% | 0.47% |
| DEUTSCHE BANK AG\ | 11/13/2025 | 184.45 K | $10.96 M | 80.18% | 0.44% |
| SANDS CAPITAL VENTURES, LLC | 11/13/2025 | 170.00 K | $10.10 M | 0.00% | 0.40% |
| RUSSELL INVESTMENTS GROUP, LTD. | 11/13/2025 | 148.33 K | $8.82 M | 2.13% | 0.35% |
| CANADA PENSION PLAN INVESTMENT BOARD | 11/13/2025 | 131.30 K | $7.80 M | 1,444.71% | 0.31% |
| ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | 10/20/2025 | 128.74 K | $7.38 M | -2.89% | 0.30% |
| TFG ASSET MANAGEMENT GP LTD | 11/14/2025 | 125.00 K | $7.43 M | -50.00% | 0.30% |
| AFFINITY ASSET ADVISORS, LLC | 11/13/2025 | 125.00 K | $7.43 M | 100.00% | 0.30% |
| MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC | 10/31/2025 | 122.34 K | $7.27 M | -8.00% | 0.29% |
| TRI LOCUM PARTNERS LP | 11/14/2025 | 119.26 K | $7.09 M | -32.87% | 0.28% |
| UBS GROUP AG | 11/13/2025 | 118.56 K | $7.05 M | 315.92% | 0.28% |
| JEFFERIES FINANCIAL GROUP INC. | 11/13/2025 | 113.07 K | $6.72 M | -30.63% | 0.27% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Tarsus Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 259 institutional investors and hedge funds held shares of Tarsus Pharmaceuticals, Inc.. The most heavily invested institutionals were:
BlackRock, Inc.: 3.78 M
RTW INVESTMENTS, LP: 3.18 M
Deep Track Capital, LP: 3 M
Paradigm Biocapital Advisors LP: 2.67 M
JENNISON ASSOCIATES LLC: 2.6 M
TANG CAPITAL MANAGEMENT LLC: 2.45 M
105.96% of Tarsus Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 52.03 M shares in the last 24 months. This purchase volume represents approximately $3.39 B in transactions.